REPORT ID 3387

EMEA (Europe, Middle East and Africa) Blood Plasma Market Report 2019

Publish Date
2019
Pages
114
Format
Electronic (PDF)

In this report, the EMEA Blood Plasma market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Blood Plasma for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Blood Plasma market competition by top manufacturers/players, with Blood Plasma sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Baxter
    CSL
    Grifols
    Octapharma
    Bayer
    Biotest
    Kedrion
    CBOP
    RAAS
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    BOYA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Human Albumin
    Gelatins
    Dextrans
    Starches
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Extensive Burns
    Massive Blood or Plasma Loss
    Hypovolemic Shock
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Blood Plasma Market  Report 2019
1 Blood Plasma Overview
    1.1 Product Overview and Scope of Blood Plasma
    1.2 Classification of Blood Plasma
        1.2.1 EMEA Blood Plasma Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Blood Plasma Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Human Albumin
        1.2.4 Gelatins
        1.2.5 Dextrans
        1.2.6 Starches
        1.2.7 Other
    1.3 EMEA Blood Plasma Market by Application/End Users
        1.3.1 EMEA Blood Plasma Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Extensive Burns
        1.3.3 Massive Blood or Plasma Loss
        1.3.4 Hypovolemic Shock
        1.3.5 Others
    1.4 EMEA Blood Plasma Market by Region
        1.4.1 EMEA Blood Plasma Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Blood Plasma ( 2014-2024)
        1.5.1 EMEA Blood Plasma Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Blood Plasma Revenue and Growth Rate ( 2014-2024)

2 EMEA Blood Plasma Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Blood Plasma Market Competition by Players/Manufacturers
        2.1.1 EMEA Blood Plasma Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Blood Plasma Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Blood Plasma Sale Price by Players ( 2014-2019)
    2.2 EMEA Blood Plasma (Volume and Value) by Type/Product Category
        2.2.1 EMEA Blood Plasma Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Blood Plasma Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Blood Plasma Sale Price by Type ( 2014-2019)
    2.3 EMEA Blood Plasma (Volume) by Application
    2.4 EMEA Blood Plasma (Volume and Value) by Region
        2.4.1 EMEA Blood Plasma Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Blood Plasma Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Blood Plasma Sales Price by Region ( 2014-2019)

3 Europe Blood Plasma (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Blood Plasma Sales and Value ( 2014-2019)
        3.1.1 Europe Blood Plasma Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Blood Plasma Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Blood Plasma Sales and Market Share by Type
    3.3 Europe Blood Plasma Sales and Market Share by Application
    3.4 Europe Blood Plasma Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Blood Plasma Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Blood Plasma Revenue by Countries ( 2014-2019)
        3.4.3 Germany Blood Plasma Sales and Growth Rate ( 2014-2019)
        3.4.4 France Blood Plasma Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Blood Plasma Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Blood Plasma Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Blood Plasma Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Blood Plasma Sales and Growth Rate ( 2014-2019)

4 Middle East Blood Plasma (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Blood Plasma Sales and Value ( 2014-2019)
        4.1.1 Middle East Blood Plasma Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Blood Plasma Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Blood Plasma Sales and Market Share by Type
    4.3 Middle East Blood Plasma Sales and Market Share by Application
    4.4 Middle East Blood Plasma Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Blood Plasma Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Blood Plasma Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Blood Plasma Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Blood Plasma Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Blood Plasma Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Blood Plasma Sales and Growth Rate ( 2014-2019)

5 Africa Blood Plasma (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Blood Plasma Sales and Value ( 2014-2019)
        5.1.1 Africa Blood Plasma Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Blood Plasma Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Blood Plasma Sales and Market Share by Type
    5.3 Africa Blood Plasma Sales and Market Share by Application
    5.4 Africa Blood Plasma Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Blood Plasma Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Blood Plasma Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Blood Plasma Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Blood Plasma Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Blood Plasma Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Blood Plasma Sales and Growth Rate ( 2014-2019)

6 EMEA Blood Plasma Manufacturers/Players Profiles and Sales Data
    6.1 Baxter
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Blood Plasma Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Baxter Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 CSL
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Blood Plasma Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CSL Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Grifols
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Blood Plasma Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Grifols Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Octapharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Blood Plasma Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Octapharma Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Bayer
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Blood Plasma Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Biotest
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Blood Plasma Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Biotest Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Kedrion
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Blood Plasma Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Kedrion Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 CBOP
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Blood Plasma Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 CBOP Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 RAAS
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Blood Plasma Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 RAAS Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Hualan Bio
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Blood Plasma Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hualan Bio Blood Plasma Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Tiantan Bio
    6.12 Shuanglin Bio
    6.13 BOYA

7 Blood Plasma Manufacturing Cost Analysis
    7.1 Blood Plasma Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Blood Plasma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Blood Plasma Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Blood Plasma Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Blood Plasma Market Forecast ( 2019-2025)
    11.1 EMEA Blood Plasma Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Blood Plasma Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Blood Plasma Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Blood Plasma Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Blood Plasma Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Blood Plasma Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Blood Plasma Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Blood Plasma Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Blood Plasma Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Blood Plasma Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer